Department of Pharmaceutical Chemistry

Dynamic modeling of cancer signaling for precision medicine: a QBI/SBI Seminar with Dirk Fey

The QBI/SBI Seminar Series on molecular networks of cancer and other diseases aims to facilitate collaborative relationships between scientists from both the US and Ireland.

Creating Healthy and Inclusive Spaces – Equity and Inclusion Speaker Series

Faculty members shared their experiences and advice on creating healthy and inclusive spaces at the lab, department, and School levels.

Stanford.Berkeley.UCSF Next Generation Faculty Symposium

About this event

Preventing the Next Pandemic: Vaccine Diplomacy in a Time of Anti-Science: a QBI online seminar with Peter Hotez

The QBI & Gladstone Institute Infectious Disease and Human Health Seminar Series present Peter Hotez, PhD, Dean of the National School of Tropical Medicine and Professor of Pediatrics, Molecular Virology & Microbiology at Baylor College of Medicine, and Professor at Baylor University.

Science in the Time of Corona: Using Cryo-EM and collaboration to understand SARS-CoV-2 antibodies

QBI TV presents Science in the Time of Corona, a live show where scientists discuss how COVID-19 has evolved science. Moderated by Robin Marks of the UCSF Office of Communications, the discussion will highlight recent research conducted by the QBI Coronavirus Research Group.

Creating Healthy and Inclusive Spaces on Campus

Join us for the next session of the Equity & Inclusion Speaker Series.

Update from the Dean: Excellence amidst change

School leadership changes, our ongoing fight against COVID-19, and the latest accomplishments of students, faculty members, and staff members

Frontiers in Epigenetics and Chromatin: From Fundamentals to the Clinic

Organized by Drs. Danica Fujimori and Geeta Narlikar, QBI presents Frontiers in Epigenetics and Chromatin: From Fundamentals to the Clinic. The symposium will be held online on September 20–21, 2021.

QBI continues research efforts to stave off future surges of COVID-19

Research into SARS-CoV-2 variants and potential therapies pushes forward